These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 39422696)

  • 1. PYCR1 promotes liver cancer cell growth and metastasis by regulating IRS1 expression through lactylation modification.
    Wang H; Xu M; Zhang T; Pan J; Li C; Pan B; Zhou L; Huang Y; Gao C; He M; Xue Y; Ji X; Zhang X; Wang N; Zhou H; Wang Q; Li JZ
    Clin Transl Med; 2024 Oct; 14(10):e70045. PubMed ID: 39422696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PYCR1 interference inhibits cell growth and survival via c-Jun N-terminal kinase/insulin receptor substrate 1 (JNK/IRS1) pathway in hepatocellular cancer.
    Zhuang J; Song Y; Ye Y; He S; Ma X; Zhang M; Ni J; Wang J; Xia W
    J Transl Med; 2019 Oct; 17(1):343. PubMed ID: 31619254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic pathway analyses identify proline biosynthesis pathway as a promoter of liver tumorigenesis.
    Ding Z; Ericksen RE; Escande-Beillard N; Lee QY; Loh A; Denil S; Steckel M; Haegebarth A; Wai Ho TS; Chow P; Toh HC; Reversade B; Gruenewald S; Han W
    J Hepatol; 2020 Apr; 72(4):725-735. PubMed ID: 31726117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deciphering the effects of PYCR1 on cell function and its associated mechanism in hepatocellular carcinoma.
    Xu Y; Zuo W; Wang X; Zhang Q; Gan X; Tan N; Jia W; Liu J; Li Z; Zhou B; Zhao D; Xie Z; Tan Y; Zheng S; Liu C; Li H; Chen Z; Yang X; Huang Z
    Int J Biol Sci; 2021; 17(9):2223-2239. PubMed ID: 34239351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shikonin induces apoptosis and autophagy via downregulation of pyrroline-5-carboxylate reductase1 in hepatocellular carcinoma cells.
    Zhang J; Shang L; Jiang W; Wu W
    Bioengineered; 2022 Mar; 13(3):7904-7918. PubMed ID: 35293266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of PYCR1 suppressed the malignant phenotype of human hepatocellular carcinoma cells via inhibiting the AKT pathway activation.
    Guo J; Cheng X; Tian Y; Li B; Zhang X; Gao X; An Y
    Reprod Biol; 2021 Sep; 21(3):100534. PubMed ID: 34271243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BHLHE41 inhibits bladder cancer progression via regulation of PYCR1 stability and thus inactivating PI3K/AKT signaling pathway.
    Xiao S; Chen J; Wei Y; Song W
    Eur J Med Res; 2024 May; 29(1):302. PubMed ID: 38811952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone lactylation facilitates hepatocellular carcinoma progression by upregulating endothelial cell-specific molecule 1 expression.
    Zhao P; Qiao C; Wang J; Zhou Y; Zhang C
    Mol Carcinog; 2024 Nov; 63(11):2078-2089. PubMed ID: 39016629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PYCR1 knockdown inhibits the proliferation, migration, and invasion by affecting JAK/STAT signaling pathway in lung adenocarcinoma.
    Gao Y; Luo L; Xie Y; Zhao Y; Yao J; Liu X
    Mol Carcinog; 2020 May; 59(5):503-511. PubMed ID: 32133692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human mitochondrial pyrroline-5-carboxylate reductase 1 promotes invasiveness and impacts survival in breast cancers.
    Ding J; Kuo ML; Su L; Xue L; Luh F; Zhang H; Wang J; Lin TG; Zhang K; Chu P; Zheng S; Liu X; Yen Y
    Carcinogenesis; 2017 May; 38(5):519-531. PubMed ID: 28379297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening a knowledge-based library of low molecular weight compounds against the proline biosynthetic enzyme 1-pyrroline-5-carboxylate 1 (PYCR1).
    Meeks KR; Bogner AN; Tanner JJ
    Protein Sci; 2024 Jul; 33(7):e5072. PubMed ID: 39133178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyrroline-5-Carboxylate Reductase 1 Accelerates the Migration and Invasion of Nonsmall Cell Lung Cancer
    Sang S; Zhang C; Shan J
    Cancer Biother Radiopharm; 2019 Aug; 34(6):380-387. PubMed ID: 30916574
    [No Abstract]   [Full Text] [Related]  

  • 13. HHLA2 promotes hepatoma cell proliferation, migration, and invasion via SPP1/PI3K/AKT signaling pathway.
    Wang J; Yang K; Yang X; Jin T; Tian Y; Dai C; Xu F
    Mol Carcinog; 2024 Jul; 63(7):1275-1287. PubMed ID: 38578157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FOXC1 promotes HCC proliferation and metastasis by Upregulating DNMT3B to induce DNA Hypermethylation of CTH promoter.
    Lin Z; Huang W; He Q; Li D; Wang Z; Feng Y; Liu D; Zhang T; Wang Y; Xie M; Ji X; Sun M; Tian D; Xia L
    J Exp Clin Cancer Res; 2021 Feb; 40(1):50. PubMed ID: 33522955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-145 suppresses hepatocellular carcinoma by targeting IRS1 and its downstream Akt signaling.
    Wang Y; Hu C; Cheng J; Chen B; Ke Q; Lv Z; Wu J; Zhou Y
    Biochem Biophys Res Commun; 2014 Apr; 446(4):1255-60. PubMed ID: 24690171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PYCR2 promotes growth and aerobic glycolysis in human liver cancer by regulating the AKT signaling pathway.
    Wang S; Yi W; Xu Z; Shi M
    Biochem Biophys Res Commun; 2023 Nov; 680():15-24. PubMed ID: 37708598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ZEB1 enhances Warburg effect to facilitate tumorigenesis and metastasis of HCC by transcriptionally activating PFKM.
    Zhou Y; Lin F; Wan T; Chen A; Wang H; Jiang B; Zhao W; Liao S; Wang S; Li G; Xu Z; Wang J; Zhang J; Ma H; Lin D; Li Q
    Theranostics; 2021; 11(12):5926-5938. PubMed ID: 33897890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CircCCNB1 silencing acting as a miR-106b-5p sponge inhibited GPM6A expression to promote HCC progression by enhancing DYNC1I1 expression and activating the AKT/ERK signaling pathway.
    Liu YM; Cao Y; Zhao PS; Wu LY; Lu YM; Wang YL; Zhao JF; Liu XG
    Int J Biol Sci; 2022; 18(2):637-651. PubMed ID: 35002514
    [No Abstract]   [Full Text] [Related]  

  • 19. Long noncoding RNA CCAT2 promotes hepatocellular carcinoma proliferation and metastasis through up-regulation of NDRG1.
    Liu Y; Wang D; Li Y; Yan S; Dang H; Yue H; Ling J; Chen F; Zhao Y; Gou L; Tang P; Huang A; Tang H
    Exp Cell Res; 2019 Jun; 379(1):19-29. PubMed ID: 30922920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homeobox B9 promotes the invasion and metastasis of hepatocellular carcinoma cells via the EZH2-MIR203A-SNAI2 axis.
    Zhang D; Qiu Y; Zhang W; Du D; Liu Y; Liu L; Li J; Chen Z; Yu X; Ye M; Wang W; Li Z; Shao J
    J Transl Med; 2024 Oct; 22(1):918. PubMed ID: 39390614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.